Development Of A Box–Behnken Design Optimized Linagliptin Liposphere Formulation For Improved Bioavailability And Sustained Release. JOC 2025, 24 (7s), 866-877. https://doi.org/10.64149/J.Carcinog.24.7s.866-877.